SCHEDULE OF INVESTMENTS (Unaudited) June 30, 2016 HEALTH CARE FUND SHARES VALUE COMMON STOCKS† - 99.6% PHARMACEUTICALS - 36.0% Johnson & Johnson 6,795 $ 824,234 Pfizer, Inc. 18,689 658,040 Merck & Company, Inc. 9,584 552,134 Bristol-Myers Squibb Co. 6,786 499,110 AbbVie, Inc. 7,179 444,452 Eli Lilly & Co. 5,379 423,596 Allergan plc* 1,825 421,739 Shire plc ADR 1,874 345,023 Express Scripts Holding Co.* 4,099 310,704 McKesson Corp. 1,592 297,147 Teva Pharmaceutical Industries Ltd. ADR 4,616 231,862 Cardinal Health, Inc. 2,934 228,881 Zoetis, Inc. 4,506 213,855 Mylan N.V.* 4,689 202,752 AmerisourceBergen Corp. — Class A 2,358 187,037 Novartis AG ADR 2,143 176,819 GlaxoSmithKline plc ADR 3,975 172,277 AstraZeneca plc ADR 5,598 169,004 Jazz Pharmaceuticals plc* 1,175 166,039 Alkermes plc* 3,820 165,100 Novo Nordisk A/S ADR 2,849 153,219 Quintiles Transnational Holdings, Inc.* 1,910 124,761 DexCom, Inc.* 1,490 118,203 Mallinckrodt plc* 1,928 117,184 Valeant Pharmaceuticals International, Inc.* 5,644 113,670 VCA, Inc.* 1,530 103,443 OPKO Health, Inc.* 10,789 100,769 Neurocrine Biosciences, Inc.* 1,940 88,173 Akorn, Inc.* 2,835 80,755 ACADIA Pharmaceuticals, Inc.* 2,390 77,579 Catalent, Inc.* 3,360 77,246 Prestige Brands Holdings, Inc.* 1,390 77,006 Horizon Pharma plc* 4,280 70,492 Owens & Minor, Inc. 1,850 69,153 Impax Laboratories, Inc.* 2,120 61,098 Radius Health, Inc.* 1,520 55,860 Agios Pharmaceuticals, Inc.* 1,240 51,950 Depomed, Inc.* 2,470 48,461 Pacira Pharmaceuticals, Inc.* 1,420 47,897 Sarepta Therapeutics, Inc.* 2,420 46,149 Relypsa, Inc.* 2,210 40,885 Total Pharmaceuticals 8,413,758 HEALTHCARE-PRODUCTS - 23.8% Abbott Laboratories 8,825 346,910 Thermo Fisher Scientific, Inc. 2,324 343,394 Medtronic plc 3,865 335,366 Stryker Corp. 2,534 303,649 Becton Dickinson and Co. 1,583 268,461 Boston Scientific Corp.* 10,844 253,424 Intuitive Surgical, Inc.* 369 244,060 Baxter International, Inc. 4,947 223,703 Zimmer Biomet Holdings, Inc. 1,840 221,499 St. Jude Medical, Inc. 2,697 210,366 Edwards Lifesciences Corp.* 2,078 207,239 CR Bard, Inc. 873 205,295 Henry Schein, Inc.* 1,052 185,994 DENTSPLY SIRONA, Inc. 2,724 168,997 STERIS plc 2,380 163,625 LivaNova plc* 2,900 145,667 Cooper Companies, Inc. 825 141,545 Hologic, Inc.* 4,046 139,992 Teleflex, Inc. 777 137,770 ResMed, Inc. 2,178 137,715 IDEXX Laboratories, Inc.* 1,410 130,933 Varian Medical Systems, Inc.* 1,531 125,894 Align Technology, Inc.* 1,403 113,012 ABIOMED, Inc.* 1,000 109,290 West Pharmaceutical Services, Inc. 1,393 105,701 Bio-Techne Corp. 880 99,238 Patterson Companies, Inc. 2,060 98,653 Alere, Inc.* 2,000 83,360 Bruker Corp. 3,650 83,001 Hill-Rom Holdings, Inc. 1,540 77,693 NuVasive, Inc.* 1,300 77,636 Cepheid* 2,150 66,113 Total Healthcare-Products 5,555,195 BIOTECHNOLOGY - 18.3% Amgen, Inc. 3,116 474,099 Gilead Sciences, Inc. 5,613 468,236 Celgene Corp.* 3,921 386,728 Biogen, Inc.* 1,339 323,797 Regeneron Pharmaceuticals, Inc.* 811 283,226 Alexion Pharmaceuticals, Inc.* 1,902 222,078 Illumina, Inc.* 1,479 207,622 Vertex Pharmaceuticals, Inc.* 2,321 199,652 Incyte Corp.* 2,150 171,957 BioMarin Pharmaceutical, Inc.* 1,980 154,044 Medivation, Inc.* 2,338 140,981 Seattle Genetics, Inc.* 2,670 107,895 United Therapeutics Corp.* 1,000 105,920 Alnylam Pharmaceuticals, Inc.* 1,747 96,941 Charles River Laboratories International, Inc.* 1,160 95,630 Intercept Pharmaceuticals, Inc.* 642 91,601 Juno Therapeutics, Inc.* 2,160 83,030 Ligand Pharmaceuticals, Inc. — Class B* 640 76,333 Intrexon Corp.* 3,020 74,322 Kite Pharma, Inc.* 1,350 67,500 Medicines Co.* 1,990 66,924 Myriad Genetics, Inc.* 2,130 65,178 Novavax, Inc.* 8,619 62,660 Bluebird Bio, Inc.* 1,340 58,009 Ultragenyx Pharmaceutical, Inc.* 1,110 54,290 ARIAD Pharmaceuticals, Inc.* 6,868 50,755 SCHEDULE OF INVESTMENTS (Unaudited)(concluded) June 30, 2016 HEALTH CARE FUND SHARES VALUE Acorda Therapeutics, Inc.* 1,900 $ 48,460 AMAG Pharmaceuticals, Inc.* 1,600 38,272 Total Biotechnology 4,276,140 HEALTHCARE-SERVICES - 15.3% UnitedHealth Group, Inc. 3,666 517,640 Aetna, Inc. 2,379 290,548 Anthem, Inc. 1,969 258,608 Cigna Corp. 1,971 252,268 HCA Holdings, Inc.* 3,165 243,736 Humana, Inc. 1,247 224,310 DaVita HealthCare Partners, Inc.* 2,314 178,918 Laboratory Corporation of America Holdings* 1,264 164,661 Universal Health Services, Inc. — Class B 1,206 161,724 Centene Corp.* 2,258 161,153 Quest Diagnostics, Inc. 1,894 154,191 MEDNAX, Inc.* 1,620 117,337 WellCare Health Plans, Inc.* 980 105,134 Envision Healthcare Holdings, Inc.* 3,890 98,689 Acadia Healthcare Company, Inc.* 1,730 95,842 Amsurg Corp. — Class A* 1,170 90,722 HealthSouth Corp. 2,090 81,134 Tenet Healthcare Corp.* 2,704 74,739 Brookdale Senior Living, Inc. — Class A* 4,800 74,112 LifePoint Health, Inc.* 1,123 73,411 Molina Healthcare, Inc.* 1,470 73,353 Community Health Systems, Inc.* 4,180 50,369 Kindred Healthcare, Inc. 3,900 44,031 Total Healthcare-Services 3,586,630 SOFTWARE - 3.0% Cerner Corp.* 3,536 207,210 IMS Health Holdings, Inc.* 5,130 130,097 athenahealth, Inc.* 840 115,928 Veeva Systems, Inc. — Class A* 2,800 95,536 Medidata Solutions, Inc.* 1,610 75,461 Allscripts Healthcare Solutions, Inc.* 5,430 68,961 Total Software 693,193 ELECTRONICS - 2.5% Agilent Technologies, Inc. 3,752 166,439 Waters Corp.* 1,183 166,388 Mettler-Toledo International, Inc.* 414 151,077 PerkinElmer, Inc. 2,030 106,413 Total Electronics 590,317 COMMERCIAL SERVICES - 0.7% PAREXEL International Corp.* 1,347 84,699 Team Health Holdings, Inc.* 1,840 74,833 Total Commercial Services 159,532 Total Common Stocks (Cost $13,358,016) 23,274,765 RIGHTS††† - 0.0% Dyax Corp. Expires 01/25/17* 3,790 — Total Rights (Cost $–) — FACE AMOUNT REPURCHASE AGREEMENT††,1 - 0.2% HSBC Group issued 06/30/16 at 0.26% due 07/01/16 $ 55,603 55,603 Total Repurchase Agreement (Cost $55,603) 55,603 Total Investments - 99.8% (Cost $13,413,619) $ 23,330,368 Other Assets & Liabilities, net - 0.2% 56,961 Total Net Assets - 100.0% $ 23,387,329 * Non-income producing security. † Value determined based on Level 1 inputs. †† Value determined based on Level 2 inputs. ††† Value determined based on Level 3 inputs. 1 Repurchase Agreement. ADR — American Depositary Receipt plc — Public Limited Company.